An estimated 42% of U.S. adults aged 30 years or older have periodontitis, with about 7.8% of those adults having severe ...

Treatment with donanemab (Kisunla) raised the risk of amyloid-related imaging abnormalities (ARIA) in people with early ...

Research organizations in Houston and San Antonio say they are eager to take advantage of the proposed fund championed by Lt.

The Ironman Triathlon is a grueling 140 miles, which includes a 2.4-mile swim, a 112-mile bike ride and a 26.2-mile marathon ...

Discover how a natural compound found in these common herbs could enhance cognitive function and ease inflammation.

Why are researchers still fumbling in the quest to cure what is arguably one of the most important diseases confronting ...

The herb rosemary has long been linked with memory: "There's rosemary, that's for remembrance," says Ophelia in Shakespeare's ...

A University of Minnesota research team was recently awarded a five-year, $3.8 million grant from the U.S. National Institutes of Health to develop a new cell therapy to combat Alzheimer's disease.

Why are researchers still fumbling in the quest to cure what is arguably one of the most important diseases confronting humankind — Alzheimer’s disease? Despite decades of research ...

AL002 misses Phase 2 goal in early Alzheimer's. Key Phase 3 data for latozinemab in 2025. Click here to read why ALEC is a ...

A new study has found that using electrical stimulation on specific brain areas may help some people with Alzheimer’s disease ...

US-based Eli Lilly's Kisunla drug and Japanese company Eisai's Leqembi (below), two breakthrough drugs for the diagnosis and ...